Contract Pharmaceuticals Limited Canada recalls Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuti
Recalled March 13, 2024 · FDA recall D-0364-2024 · Contract Pharmaceuticals Limited Canada
Hazard
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint. · FDA Class III
Units
45,875 bottles
Sold at
Nationwide in the U.S. and Puerto Rico
Description
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Product
Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61
Manufacturer(s)
Contract Pharmaceuticals Limited Canada
Made in
Canada
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →